A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up
Completed
- Conditions
- Recurrent Pulmonary Embolism (Disorder)
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2022-04-06
- Lead Sponsor
- NC Heart and Vascular Research, LLC
- Target Recruit Count
- 11
- Registration Number
- NCT04208139
- Locations
- 🇺🇸
NC Heart and Vascular Research, LLC, Raleigh, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath